Cas:128996-12-3 1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine manufacturer & supplier

Chemical Name:1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine

CAS.NO:128996-12-3

Synonyms:1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine;Piperazine, 1-[3-(dimethoxymethylsilyl)propyl]-;MFCD12032181

Molecular Formula:C₁₀H₂₄N₂O₂Si

Molecular Weight:232.395

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:279.6±0.0 °C at 760 mmHg

Density:0.9±0.0 g/cm3

Index of Refraction:1.445

PSA:

Exact Mass:232.160706

LogP:-0.32

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD12032181 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Piperazine, 1-[3-(dimethoxymethylsilyl)propyl]- Use and application,Piperazine, 1-[3-(dimethoxymethylsilyl)propyl]- technical grade,usp/ep/jp grade.

Related News: Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. 1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine manufacturer In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine supplier The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine vendor Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 1-{3-[Dimethoxy(methyl)silyl]propyl}piperazine factory The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.